28449310|t|RATIONAL DESIGN OF NANOBODY80 LOOP PEPTIDOMIMETICS: TOWARDS BIASED β2 ADRENERGIC RECEPTOR LIGANDS
28449310|a|G protein-coupled receptors (GPCRs) play an important role for many cellular responses, and as such their mechanism of action is of utmost interest. To gain insight into the active conformation of GPCRs, the X-ray crystal structures of Nanobody(Nb) -stabilized β2-adrenergic receptor (β2AR) have been reported. Nb80 in particular is able to bind the intracellular G protein binding site of β2AR and stabilize the receptors in an active conformation. Within Nb80, the complementarity-determining region 3 (CDR3) is responsible for most of the binding interactions. Hence we hypothesized that peptidomimetics of the CDR3 loop might be sufficient for binding to the receptor, inhibiting the interaction of β2AR with intracellular GPCR interacting proteins (e.g. G proteins). Based on previous crystallographic data, a set of peptidomimetics were synthesized which, similarly to the Nb80 CDR3 loop, adopt a  -hairpin conformation. Syntheses, conformationa l analysis, binding and functional in vitro assays, as well as internalization experiments were performed. We demonstrate that peptidomimetics can structurally mimic the CDR3 loop of a Nanobody and its function by inhibiting G protein coupling as measured by partial inhibition of cAMP production.
28449310	19	29	NANOBODY80	T116,T129	C4276535
28449310	30	34	LOOP	T082	C0445022
28449310	35	50	PEPTIDOMIMETICS	T121	C2936235
28449310	60	66	BIASED	T078	C0242568
28449310	67	97	β2 ADRENERGIC RECEPTOR LIGANDS	T044	C1623230
28449310	98	125	G protein-coupled receptors	T116,T192	C0682972
28449310	127	132	GPCRs	T116,T192	C0682972
28449310	166	184	cellular responses	T039	C1659608
28449310	204	223	mechanism of action	T039	C0031327
28449310	279	291	conformation	T082	C0026377
28449310	295	300	GPCRs	T116,T192	C0682972
28449310	306	311	X-ray	T070	C0043309
28449310	312	330	crystal structures	T026	C0230587
28449310	334	346	Nanobody(Nb)	T116,T129	C4276535
28449310	359	381	β2-adrenergic receptor	T116,T192	C0001643
28449310	383	387	β2AR	T116,T192	C0001643
28449310	409	413	Nb80	T116,T129	C4276535
28449310	439	443	bind	T044	C1167622
28449310	448	461	intracellular	T082	C0178719
28449310	462	471	G protein	T116,T126	C0086376
28449310	472	484	binding site	T087	C1514535
28449310	488	492	β2AR	T116,T192	C0001643
28449310	511	520	receptors	T116,T192	C0597357
28449310	527	546	active conformation	T082	C0033625
28449310	555	559	Nb80	T116,T129	C4276535
28449310	565	601	complementarity-determining region 3	T116,T129	C0887928
28449310	603	607	CDR3	T116,T129	C0887928
28449310	640	660	binding interactions	T044	C1167622
28449310	689	704	peptidomimetics	T121	C2936235
28449310	712	716	CDR3	T116,T129	C0887928
28449310	717	721	loop	T082	C0445022
28449310	746	769	binding to the receptor	T044	C0597358
28449310	771	781	inhibiting	T044	C3269586
28449310	786	797	interaction	T044	C1167622
28449310	801	805	β2AR	T116,T192	C0001643
28449310	811	824	intracellular	T082	C0178719
28449310	825	841	GPCR interacting	T044	C1749317
28449310	842	850	proteins	T116,T123	C0033684
28449310	857	867	G proteins	T116,T126	C0086376
28449310	888	909	crystallographic data	T059	C0010424
28449310	920	935	peptidomimetics	T121	C2936235
28449310	941	952	synthesized	T052	C1883254
28449310	977	981	Nb80	T116,T129	C4276535
28449310	982	986	CDR3	T116,T129	C0887928
28449310	987	991	loop	T082	C0445022
28449310	1003	1024	-hairpin conformation	T082	C1518960
28449310	1026	1035	Syntheses	T052	C3178925
28449310	1037	1050	conformationa	T082	C1518960
28449310	1063	1070	binding	T044	C1167622
28449310	1086	1101	in vitro assays	T062	C1515653
28449310	1114	1129	internalization	T067	C0599281
28449310	1178	1193	peptidomimetics	T121	C2936235
28449310	1198	1210	structurally	T085	C0026383
28449310	1221	1225	CDR3	T116,T129	C0887928
28449310	1226	1230	loop	T082	C0445022
28449310	1236	1244	Nanobody	T116,T129	C4276535
28449310	1253	1261	function	T044	C1527118
28449310	1265	1275	inhibiting	T040	C2245433
28449310	1276	1294	G protein coupling	T044	C1819628
28449310	1310	1317	partial	T081	C0728938
28449310	1318	1328	inhibition	T052	C3463820
28449310	1332	1347	cAMP production	T044	C1157594